Showing 96 of 96on this page. Filters & sort apply to loaded results; URL updates for sharing.96 of 96 on this page
Carrick Therapeutics Declares the U.S. FDA Approval the IND for CT7439 ...
Abstract 7004: CT7439 an oral first-in class selective CDK12 and 13 ...
Thanks to all those that came along to see Carrick Therapeutics poster ...
FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat ...
Development of an orally bioavailable CDK12/13 degrader and induction ...
(CT-7439)-药物靶点：CCNK + CDK12 + CDK13_在研适应症：乳腺癌，尤文肉瘤，卵巢癌_专利_临床_研发
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin ...
Discovery and design of molecular glue enhancers of CDK12–DDB1 ...
PAF1C-mediated activation of CDK12/13 kinase activity is critical for ...
The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes ...
CDK Inhibitors and FDA: Approved and Orphan
Targeting transcription in heart failure via CDK7/12/13 inhibition - PMC
CDK12 Inhibitor CTX-439 | Science/Pipleline | Chordia Therapeutics Inc.
Chemical inhibition of CDK12/13 deeply impaired the DDR in MYC-driven ...
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable ...
Figure 4 from Covalent targeting of remote cysteine residues to develop ...
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer ...
Structural Mass Spectrometry Probes the Inhibitor-Induced Allosteric ...
CDK13 phosphorylates the translation machinery and promotes tumorigenic ...
Research progress of anticancer drugs targeting CDK12 - RSC Medicinal ...
The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by ...
Home | Chordia Therapeutics Inc.
Emerging approaches to CDK inhibitor development, a structural ...
Highlights of the Latest Advances in Research on CDK Inhibitors
Synthetic Approaches and Clinical Application of Representative Small ...
The Renaissance of Cyclin Dependent Kinase Inhibitors
An Updated Review on Developing Small Molecule Kinase Inhibitors Using ...
(PDF) The CDK inhibitor AT7519 inhibits human glioblastoma cell growth ...
Pharmaceuticals | Free Full-Text | Novel 2,6,9-Trisubstituted Purines ...
CCT241533 | CAS 1262849-73-9 | SCBT - Santa Cruz Biotechnology
Exploring cyclin-dependent kinase inhibitors: a comprehensive study in ...
Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating ...
Structure of select CDK9 inhibitors discussed in this paper ...
Enzyme inhibition activity of compound 79 against the Cdk family and ...
Addressing Transcriptional Dysregulation in Cancer through CDK9 ...
CDK | 细胞周期蛋白依赖性激酶 | 抑制剂 | MCE
Molecules | Free Full-Text | Targeting Transcriptional CDKs 7, 8, and 9 ...
Structure and activity of selective CDK7 and CDK9 inhibitors ...
美国APExBIO中文官网 - ZM 447439|Aurora Kinase inhibitor,potent and selective ...
Identification of a Novel Selective CDK9 Inhibitor for the Treatment of ...
Recent Progress in CDK4/6 Inhibitors and PROTACs
Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small ...
CAY10572 (PHA-767491), Cdc7 and Cdk9 kinase inhibitor (ab144419) | Abcam
Journal of Medicinal Chemistry Vol. 63 No. 22 - ACS Publications
